L. Cals

1.2k total citations
41 papers, 674 citations indexed

About

L. Cals is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, L. Cals has authored 41 papers receiving a total of 674 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 11 papers in Cancer Research. Recurrent topics in L. Cals's work include Cancer Treatment and Pharmacology (15 papers), Breast Cancer Treatment Studies (11 papers) and Colorectal Cancer Treatments and Studies (8 papers). L. Cals is often cited by papers focused on Cancer Treatment and Pharmacology (15 papers), Breast Cancer Treatment Studies (11 papers) and Colorectal Cancer Treatments and Studies (8 papers). L. Cals collaborates with scholars based in France, Belgium and Germany. L. Cals's co-authors include Xavier Pivot, Jean‐Luc Raoul, Catherine Brézault, Jean‐Luc Van Laethem, Marc Peeters, Fernando Bazán, L. Chaigneau, Cristian Villanueva, Jean-Claude Vedovato and P. Rougier and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

L. Cals

40 papers receiving 651 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Cals France 15 495 253 109 102 80 41 674
D. Turci Italy 14 492 1.0× 250 1.0× 109 1.0× 64 0.6× 120 1.5× 43 637
S. Palmeri Italy 17 584 1.2× 228 0.9× 127 1.2× 116 1.1× 91 1.1× 78 821
P. Comella Italy 19 656 1.3× 378 1.5× 143 1.3× 142 1.4× 82 1.0× 65 829
L. Kayitalire France 17 745 1.5× 453 1.8× 173 1.6× 160 1.6× 27 0.3× 40 1.1k
Zhong-Zhen Guan China 10 365 0.7× 157 0.6× 77 0.7× 51 0.5× 111 1.4× 13 488
Luigi Maiorino Italy 18 879 1.8× 706 2.8× 121 1.1× 231 2.3× 105 1.3× 47 1.2k
Giuseppe Comella Italy 16 817 1.7× 642 2.5× 88 0.8× 112 1.1× 35 0.4× 42 1.1k
B. Schüll Austria 14 639 1.3× 250 1.0× 128 1.2× 163 1.6× 108 1.4× 17 860
Miah Hiang Tay Singapore 11 157 0.3× 207 0.8× 59 0.5× 76 0.7× 73 0.9× 23 437
Mona Fouad Egypt 16 638 1.3× 278 1.1× 95 0.9× 51 0.5× 55 0.7× 32 896

Countries citing papers authored by L. Cals

Since Specialization
Citations

This map shows the geographic impact of L. Cals's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Cals with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Cals more than expected).

Fields of papers citing papers by L. Cals

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Cals. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Cals. The network helps show where L. Cals may publish in the future.

Co-authorship network of co-authors of L. Cals

This figure shows the co-authorship network connecting the top 25 collaborators of L. Cals. A scholar is included among the top collaborators of L. Cals based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Cals. L. Cals is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nerich, Virginie, Elsa Curtit, Fernando Bazán, et al.. (2014). Évaluation économique de l’utilisation en routine du test Oncotype DX® dans la prise en charge des cancers du sein en Franche-Comté. Bulletin du Cancer. 101(7-8). 681–689. 6 indexed citations
2.
Curtit, Elsa, Virginie Nerich, Laura Mansi, et al.. (2013). Discordances in Estrogen Receptor Status, Progesterone Receptor Status, and HER2 Status Between Primary Breast Cancer and Metastasis. The Oncologist. 18(6). 667–674. 73 indexed citations
3.
Fiteni, Frédéric, Cristian Villanueva, Fernando Bazán, et al.. (2013). Long-term follow-up of patients with metastatic breast cancer treated by trastuzumab: Impact of institutions. The Breast. 23(2). 165–169. 9 indexed citations
4.
5.
Dobi, Erion, Fernando Bazán, Armelle Dufresne, et al.. (2012). Is extracapsular tumour spread a prognostic factor in patients with early breast cancer?. International Journal of Clinical Oncology. 18(4). 607–613. 14 indexed citations
6.
Ray‐Coquard, Isabelle, Jean‐François Morère, Florian Scotté, L. Cals, & Éric-Charles Antoine. (2012). Management of Anemia in Advanced Breast and Lung Cancer Patients in Daily Practice: Results of a French Survey. Advances in Therapy. 29(2). 124–133. 14 indexed citations
7.
Curtit, Elsa, Nadine Dohollou, E. Lévy, et al.. (2011). Myotax: A phase II trial of docetaxel plus non-pegylated liposomal doxorubicin as first-line therapy of metastatic breast cancer previously treated with adjuvant anthracyclines. European Journal of Cancer. 47(16). 2396–2402. 9 indexed citations
8.
Villanueva, Cristian, Fernando Bazán, Stéfano Kim, et al.. (2011). Cabazitaxel. Drugs. 71(10). 1251–1258. 41 indexed citations
9.
Pivot, Xavier, Fernando Bazán, Antoine Thiery-Vuillemin, et al.. (2009). F12 How safe is bevacizumab for elderly patients?. Critical Reviews in Oncology/Hematology. 72(1). S10–S10. 1 indexed citations
10.
Raoul, Jean‐Luc, Jean‐Luc Van Laethem, Marc Peeters, et al.. (2009). Cetuximab in combination with irinotecan/5-fluorouracil/folinic acid (FOLFIRI) in the initial treatment of metastatic colorectal cancer: a multicentre two-part phase I/II study. BMC Cancer. 9(1). 112–112. 41 indexed citations
11.
Eisinger, François, L. Cals, Jean‐Yves Blay, et al.. (2008). Impact of organised programs on colorectal cancer screening. BMC Cancer. 8(1). 19 indexed citations
12.
Eisinger, François, Jean‐Yves Blay, Jean‐François Morère, et al.. (2007). Cancer screening in France: subjects’ and physicians’ attitudes. Cancer Causes & Control. 19(4). 431–434. 19 indexed citations
13.
Magné, Nicolas, Marie-Christine Étienne-Grimaldi, L. Cals, et al.. (2007). Dihydropyrimidine dehydrogenase activity and the IVS14+1G>A mutation in patients developing 5FU‐related toxicity. British Journal of Clinical Pharmacology. 64(2). 237–240. 30 indexed citations
14.
Peeters, Marc, Jean‐Luc Raoul, Jean‐Luc Van Laethem, et al.. (2005). Cetuximab in combination with irinotecan/5-fluorouracil (5-FU)/folinic acid (FA) (FOLFIRI) in the first-line treatment of metastatic colorectal cancer (mCRC). Ghent University Academic Bibliography (Ghent University). 17 indexed citations
15.
Cals, L., Olivier Rixe, Éric François, et al.. (2004). Dose-finding study of weekly 24-h continuous infusion of 5-fluorouracil associated with alternating oxaliplatin or irinotecan in advanced colorectal cancer patients. Annals of Oncology. 15(7). 1018–1024. 23 indexed citations
16.
Cals, L., et al.. (2004). Weekly Combination of Docetaxel and Vinorelbine in Metastatic Breast Cancer: A Phase I/II Study. Oncology. 67(3-4). 257–261. 6 indexed citations
17.
Rougier, P., Jean‐Luc Raoul, Jean‐Luc Van Laethem, et al.. (2004). Cetuximab+FOLFIRI as first-line treatment for metastatic colorectal CA. Journal of Clinical Oncology. 22(14_suppl). 3513–3513. 77 indexed citations
18.
Pivot, Xavier, Éric Raymond, Brigitte Laguerre, et al.. (2001). Pemetrexed disodium in recurrent locally advanced or metastatic squamous cell carcinoma of the head and neck. British Journal of Cancer. 85(5). 649–655. 67 indexed citations
19.
Pivot, Xavier, L. Cals, Didier Cupissol, et al.. (2000). Phase II Trial of a Paclitaxel-Carboplatin Combination in Recurrent Squamous Cell Carcinoma of the Head and Neck. Oncology. 60(1). 66–71. 33 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D. Turci Breakdown of academic impact, for papers by S. Palmeri Breakdown of academic impact, for papers by P. Comella Breakdown of academic impact, for papers by L. Kayitalire Breakdown of academic impact, for papers by Zhong-Zhen Guan Breakdown of academic impact, for papers by Luigi Maiorino Breakdown of academic impact, for papers by Giuseppe Comella Breakdown of academic impact, for papers by B. Schüll Breakdown of academic impact, for papers by Miah Hiang Tay Breakdown of academic impact, for papers by Mona Fouad
Rankless by CCL
2026